| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | NVP-231 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | BRD-A02303741 | CTRPv2 | pan-cancer | AAC | -0.064 | 0.1 |
| mRNA | Cerulenin | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | tanespimycin:bortezomib (250:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.062 | 0.1 |
| mRNA | tigecycline | CTRPv2 | pan-cancer | AAC | 0.079 | 0.1 |
| mRNA | paclitaxel | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | NVP-BSK805 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.1 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.083 | 0.1 |
| mRNA | clofarabine | CTRPv2 | pan-cancer | AAC | 0.047 | 0.1 |
| mRNA | BRD-K58730230 | CTRPv2 | pan-cancer | AAC | -0.12 | 0.1 |